Novartis on Track for Record High Closing -- Data Talk

Dow Jones02-14

Novartis AG Sponsored ADR $(NVS)$ is currently at $162.73, up $1.55 or 0.96%

 

--Would be new all-time closing high (Based on available data back to Dec. 24, 1996)

--On pace for largest percent increase since Feb. 11, 2026, when it rose 1.18%

--Currently up nine of the past 10 days

--Currently up eight consecutive days; up 8.59% over this period

--Longest winning streak since Aug. 30, 2024, when it rose for 11 straight trading days

--Best eight day stretch since the eight days ending Aug. 20, 2025, when it rose 8.91%

--Up 4.03% this week; best weekly performance since the week ending Feb. 6, 2026, when it rose 5.21%

--Up 9.45% month-to-date

--Up 18.03% year-to-date

--Up 54.35% from 52 weeks ago (Feb. 14, 2025), when it closed at $105.43

--Would be a new 52-week closing high

--Up 59.6% from its 52-week closing low of $101.96 on April 8, 2025

--Traded as high as $163.17; new all-time intraday high (Based on available data back to Dec. 24, 1996)

--Up 1.23% at today's intraday high

 

All data as of 12:03:49 PM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

February 13, 2026 12:06 ET (17:06 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment